My Framer Site

Commercialization, reimagined.

Portrait, white background flowing into a dark top

The reality

Innovation is not the problem. The gap between approval and access is.

The result? Promising therapies can remain commercially underdeveloped.

This is the gap LUMYNA exists to close.

Portrait, black background flowing into a white shirt

What we are

A boutique life sciences commercialization and advisory platform.

Our approach

From insight to execution. From execution to impact.

Four capabilities

One integrated platform.

Clarity before action.

The best commercial decisions start with understanding what actually matters. LUMYNA works with leadership teams, investors and innovators on the strategic questions that determine commercial value.

Commercial Strategy / Market & Opportunity Assessment / Commercial Due Diligence / Asset Evaluation / Portfolio Strategy / Go-to-Market Strategy / Organizational Design / Interim & Fractional Leadership

Strategy is only valuable when it changes something.

Advisory →

From value proposition to patient access.

Market access is not the final step of commercialization. It starts much earlier. We help clients understand the economics, stakeholders and reimbursement realities that determine whether an innovative therapy can reach patients.

Market Access Strategy / Pricing & Reimbursement / HTA / Value Proposition / Stakeholder Engagement / Early Access / Patient Access Models

No access. No impact.

Access →

From approval to adoption.

Regulatory approval opens the door. Commercial execution gets you through it. LUMYNA supports companies from launch strategy through hands-on commercial execution.

Launch Strategy / Commercial Operations / Sales & Marketing / Market Development / Medical Affairs Support / Distribution Models / Commercial Excellence / Performance Management

We don’t just launch products. We build markets.

Commercialization →

Beyond the first market.

European growth rarely follows a straight line. We help innovative companies navigate fragmented markets, identify the right partners and build scalable expansion strategies.

International Expansion / Business Development / Licensing / Partnering / Alliance Management / Market Entry / Portfolio Expansion / Growth Strategy

One market can become a platform for growth.

Growth →

Why LUMYNA

Boutique by design.

Small by design. Senior by default.

The LUMYNA difference

We don’t stop at strategy.

That is the difference between advising on commercialization and actually being a commercialization partner.

The LUMYNA model

One partner. Multiple ways to engage.

Rare disease

When every patient matters.

Because rare should never mean unreachable.

Europe

One continent. 30+ commercial realities.

Europe is not one market. It is a collection of healthcare systems, reimbursement environments, stakeholder ecosystems and commercial realities.

What works in Germany may not work in France. What works in France may not work in Italy. And what works in Italy may need to be completely rethought for the Nordics.

This fragmentation creates complexity. But it also creates opportunity. LUMYNA helps clients navigate that complexity with a market-by-market approach — while maintaining one coherent European strategy.

One vision. Local intelligence. Connected execution.

Who we work with

You built the science. We help build what comes next.

For emerging biotech, building a full European commercial infrastructure can be expensive, slow and difficult to scale. LUMYNA offers another route: senior expertise without unnecessary infrastructure.

Commercial strategy / Market access / Partnering / Market entry / Launch / Commercial execution

From first market assessment to first launch — and beyond.

For Biotech →

Commercial insight creates investment insight.

The commercial potential of a life sciences asset is often hidden inside market complexity. LUMYNA brings an operator’s perspective to investment decisions.

Market attractiveness / Competitive dynamics / Pricing & reimbursement / Commercial potential / Launch feasibility / Market-entry requirements / Portfolio opportunities / Growth potential

We don’t just assess the market. We understand what it takes to win in it.

For Investors →

The LUMYNA ecosystem

One platform. Five capabilities.

Our philosophy

Less complexity. More clarity. Better execution.

Clarity creates confidence. Confidence creates action. Action creates impact.

About LUMYNA

Built by operators.

Insights

Perspectives on life sciences.

Innovation deserves patients.

LUMYNA brings it together.

From science to market. From market to patients.

Have an asset that could go further?

LUMYNA

Commercialization, reimagined.

Advisory

Access

Commercialization

Growth

Zurich · Switzerland

Contact

Privacy

Legal